CompletedNCT00545142
Aripiprazole added to divalproex for acute mania in bipolarity
About this title
Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
Read the official source — NCT00545142Medication studyAges 18–65South Korea
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- SeoulSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateOctober 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 280
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- South Korea
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00545142
- Official title
Show the full official title
Multi-center, Single Arm, Open Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify With Depakote in the 6-week Treatment of Acute Mania in Patients With Bipolar Disorder
Get this study by email
Recruitment & locations
CompletedSeoul
Questions about this study
Who is behind this study?
The study sponsor is Korea Otsuka Pharmaceutical Co., Ltd., a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including Abilify(Aripiprazole) and Depakote(Divalproate).
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
Want to explore more studies?
Explore studiesRelated studies
A Cariprazine Study in the Prevention of Relapse in Bipolarity type I Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features
Long-term aripiprazole with a mood stabilizer for mania in bipolarity